GLI2 and breast carcinoma: Additionally, a marginal association (p = 0.05) was found between the variant rs4849887 in the LINC01101-GLI2 gene and an increased risk for clinic stage (UICC) III and IV breast cancer in the recessive model, with an OR of 2.39 (1.04-5.46) for the genotype T/T.